[email protected]

USA: +1 347 690-0211 | UK: +44 2032 894158 | Translate : 

Search Market Research Report

Discover Our Latest Reports
Discover Our Featured Reports
Discover Top Selling Reports
  1. Home
  2. Healthcare
  3. Inflammatory Bowel Disease Treatment Market

Inflammatory Bowel Disease Treatment Market Size, Share Global Analysis Report, 2019 – 2026

report img

Inflammatory Bowel Disease Treatment Market By Product (Crohn Diseases and Ulcerative Diseases), By Route of Administration (Orals and Parentals) By Distributon channel (Hospitals Pharmacy, Retail Pharmacy and Others Pharmacy): Global Industry Perspective, Comprehensive Analysis, and Forecast 2019 – 2026

Industry Insights

The Inflammatory Bowel Disease Treatment market report analyzes and notifies the industry statistics at the global as well as regional and country levels to acquire a thorough perspective of the entire Inflammatory Bowel Disease Treatment market. The historical and past insights are provided for FY 2016 to FY 2019 whereas projected trends are delivered for FY 2020 to FY 2026. The quantitative and numerical data is represented in terms of value in USD Million from FY 2016 – 2026.

This specialized and expertise-oriented industry research report scrutinizes the technical and commercial business outlook of the Inflammatory Bowel Disease Treatment industry. The report analyzes and declares the historical and current trends analysis of the Inflammatory Bowel Disease Treatment industry and subsequently recommends the projected trends anticipated to be observed in the Inflammatory Bowel Disease Treatment market during the upcoming years.

Inflammatory Bowel Disease Treatment Market Size

To know more about this report | Request Free Sample Copy

logoKey Insights from Primary Research

  • As per our primary respondents, the global inflammatory bowel disease market is set to grow annually at a rate of around 4.52%.
  • It was established through primary research that the global inflammatory bowel disease market was valued at around USD 15,509.22 Million in 2019.
  • The “Crohn’s Diseases” category, on the basis of product segmentation, was the leading revenue-generating category in 2019.
  • On the basis of end-user segmentation, the “Hospital Pharmacy” category was the leading revenue-generating category in 2019.
  • Based on the region, North America was the leading revenue-generating category in 2019.

logoKey Recommendations from Analysts

  • As per our analysis, the global inflammatory bowel disease market is growing at a high CAGR and various end-use industries are aware of this potential market and applications of inflammatory bowel disease.
  • Growing at a CAGR of around 4.52%, the global inflammatory bowel disease market provides numerous opportunities for all of the involved stakeholders across the entire value chain.
  • Our analysts have identified hospitals and retail Pharmacy segments will be dominating for global inflammatory bowel disease market in terms of product and end-user segmentation respectively.
  • As per our analysis, North America is expected to account for maximum revenue share, in the target market.

The quantitative data is further underlined and reinforced by comprehensive qualitative data which comprises various across-the-board market dynamics. The rationales which directly or indirectly impact the Inflammatory Bowel Disease Treatment industry are exemplified through parameters such as growth drivers, restraints, challenges, and opportunities among other impacting factors.

Throughout our research report, we have encompassed all the proven models and tools of industry analysis and extensively illustrated all the key business strategies and business models adopted in the Inflammatory Bowel Disease Treatment industry. The report provides an all-inclusive and detailed competitive landscape prevalent in the Inflammatory Bowel Disease Treatment market.

The report utilizes established industry analysis tools and models such as Porter’s Five Forces framework to analyze and recognize critical business strategies adopted by various stakeholders involved in the entire value chain of the Inflammatory Bowel Disease Treatment industry. The Inflammatory Bowel Disease Treatment market report additionally employs SWOT analysis and PESTLE analysis models for further in-depth analysis.

The report study further includes an in-depth analysis of industry players' market shares and provides an overview of leading players' market position in the Inflammatory Bowel Disease Treatment sector. Key strategic developments in the Inflammatory Bowel Disease Treatment market competitive landscape such as acquisitions & mergers, inaugurations of different products and services, partnerships & joint ventures, MoU agreements, VC & funding activities, R&D activities, and geographic expansion among other noteworthy activities by key players of the Inflammatory Bowel Disease Treatment market are appropriately highlighted in the report.

The Inflammatory Bowel Disease Treatment market is estimated to develop with a healthy CAGR in upcoming years. Gastrointestinal disorders increasing day by day and eating habits are considered major drivers for this market. Nonetheless, ongoing research and development will bring huge opportunities within the forecast periods

The global Inflammatory Bowel Disease Treatment market has been segmented on the basis of product, end-user, and application. On the basis of product segment the target market is segmented into Crohn's Disease and Ulcerative Diseases. On the basis of the route of the drug administration segment the global market is segmented into orals and Parentrals. On the basis of end-Users, the Market is classified into hospitals, Pharmacy, and others

logoReport Scope

Report Attribute

Details

Market Size in 2019

USD 15,509.22 Million

Projected Market Size in 2026

USD 21,888.23 Million

CAGR Growth Rate

4.41% CAGR

Base Year

2019

Forecast Years

2020-2026

Key Market Players

Johnson & Johnson Services Inc.; Pfizer Inc.; AbbVie Inc.; Takeda Pharmaceutical Company Limited, Celltrion Healthcare Co., Ltd.; CELGENE CORPORATION; COSMO PHARMACEUTICALS; Innovate Biopharmaceuticals; UCB S.A.; and Gilead Sciences., and others.

Key Segment

By Product, Route of Administration, Application, and Region

Major Regions Covered

North America, Europe, Asia Pacific, Latin America, and the Middle East &, Africa

Purchase Options

Request customized purchase options to meet your research needs. Explore purchase options

logoSome of the most important market players in the global Inflammatory Bowel Disease Treatment market

  • Johnson & Johnson Services Inc.
  •  Pfizer Inc.
  •  Takeda Pharmaceutical Company Limited
  •  AbbVie Inc.
  •  Celltrion Healthcare Co.  Ltd.
  •  CELGENE CORPORATION
  •  COSMO PHARMACEUTICALS
  •  Innovate Biopharmaceuticals
  •  UCB S.A.
  • Gilead Sciences

The taxonomy of the Inflammatory Bowel Disease Treatment  Market by its scope and segmentation is as follows:

logoGlobal Inflammatory Bowel Disease Treatment  Market: Product Segment Analysis

  • Crohn’s disease
  • Ulcerative colitis

logoGlobal Inflammatory Bowel Disease Treatment  Market: Route of Administration Segment Analysis

  • Injectables
    • TNF-inhibitors
    • IL inhibitors
    • Anti-integrin
    • Others
  • Oral
    • ASAs
    • Corticosteroids
    • JAK inhibitors
    • Others

logoGlobal Inflammatory Bowel Disease Treatment  Market: Application Segment Analysis

  • Hospital Pharmacy
  • Retail Pharmacy
  • Others Pharmacy

logoGlobal Inflammatory Bowel Disease Treatment  Market: By Region Segment Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest Of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • The Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of the Middle East & Africa

Table of Content

CHAPTER 1.... Executive Summary

CHAPTER 2.... Inflammatory Bowel Disease Treatment market – Type Analysis

2.1.        Global Inflammatory Bowel Disease Treatment Market – Type Overview

2.2.        Global Inflammatory Bowel Disease Treatment Market Share, by Type, 2019 & 2026 (USD Million)

2.3.        Crohn’s disease

2.3.1.     Global Crohn’s disease Inflammatory Bowel Disease Treatment Market, 2016-2026 (USD Million)

2.4.        Ulcerative colitis

2.4.1.     Global Ulcerative colitis Inflammatory Bowel Disease Treatment Market, 2016-2026 (USD Million)

CHAPTER 3.... Inflammatory Bowel Disease Treatment market – Route of Administration Analysis

3.1.        Global Inflammatory Bowel Disease Treatment Market – Route of Administration Overview

3.2.        Global Inflammatory Bowel Disease Treatment Market Share, by Route of Administration, 2019 & 2026 (USD Million)

3.3.        Injectables

3.3.1.     Global Injectables Inflammatory Bowel Disease Treatment Market, 2016-2026 (USD Million)

3.4.        Oral

3.4.1.     Global Oral Inflammatory Bowel Disease Treatment Market, 2016-2026 (USD Million)

CHAPTER 4.... Inflammatory Bowel Disease Treatment market – Distribution Channel Analysis

4.1.        Global Inflammatory Bowel Disease Treatment Market – Distribution Channel Overview

4.2.        Global Inflammatory Bowel Disease Treatment Market Share, by Distribution Channel, 2019 & 2026 (USD Million)

4.3.        Hospital Pharmacy

4.3.1.     Global Hospital Pharmacy Inflammatory Bowel Disease Treatment Market, 2016-2026 (USD Million)

4.4.        Retail Pharmacy

4.4.1.     Global Retail Pharmacy Inflammatory Bowel Disease Treatment Market, 2016-2026 (USD Million)

4.5.        Other Pharmacy

4.5.1.     Global Other Pharmacy Inflammatory Bowel Disease Treatment Market, 2016-2026 (USD Million)

CHAPTER 5.... Inflammatory Bowel Disease Treatment market – Regional Analysis

5.1.        Global Inflammatory Bowel Disease Treatment Market Regional Overview

5.2.        Global Inflammatory Bowel Disease Treatment Market Share, by Region, 2019 & 2026 (Value)

5.3.        North America

5.3.1.     North America Inflammatory Bowel Disease Treatment Market size and forecast, 2016-2026

5.3.2.     North America Inflammatory Bowel Disease Treatment Market, by Country, 2019 & 2026 (USD Million)

5.3.3.     North America Inflammatory Bowel Disease Treatment Market, by Type, 2016-2026

5.3.3.1.         North America Inflammatory Bowel Disease Treatment Market, by Type, 2016-2026 (USD Million)

5.3.4.     North America Inflammatory Bowel Disease Treatment Market, by Route of Administration, 2016-2026

5.3.4.1.         North America Inflammatory Bowel Disease Treatment Market, by Route of Administration, 2016-2026 (USD Million)

5.3.5.     North America Inflammatory Bowel Disease Treatment Market, by Distribution Channel, 2016-2026

5.3.5.1.         North America Inflammatory Bowel Disease Treatment Market, by Distribution Channel, 2016-2026 (USD Million)

5.3.6.     U.S.

5.3.6.1.         U.S. Market size and forecast, 2016-2026 (USD Million)

5.3.7.     Canada

5.3.7.1.         Canada Market size and forecast, 2016-2026 (USD Million)

5.4.        Europe

5.4.1.     Europe Inflammatory Bowel Disease Treatment Market size and forecast, 2016-2026

5.4.2.     Europe Inflammatory Bowel Disease Treatment Market, by Country, 2019 & 2026 (USD Million)

5.4.3.     Europe Inflammatory Bowel Disease Treatment Market, by Type, 2016-2026

5.4.3.1.         Europe Inflammatory Bowel Disease Treatment Market, by Type, 2016-2026 (USD Million)

5.4.4.     Europe Inflammatory Bowel Disease Treatment Market, by Route of Administration, 2016-2026

5.4.4.1.         Europe Inflammatory Bowel Disease Treatment Market, by Route of Administration, 2016-2026 (USD Million)

5.4.5.     Europe Inflammatory Bowel Disease Treatment Market, by Distribution Channel, 2016-2026

5.4.5.1.         Europe Inflammatory Bowel Disease Treatment Market, by Distribution Channel, 2016-2026 (USD Million)

5.4.6.     Germany

5.4.6.1.         Germany Market size and forecast, 2016-2026 (USD Million)

5.4.7.     France

5.4.7.1.         France Market size and forecast, 2016-2026 (USD Million)

5.4.8.     U.K.

5.4.8.1.         U.K. Market size and forecast, 2016-2026 (USD Million)

5.4.9.     Italy

5.4.9.1.         Italy Market size and forecast, 2016-2026 (USD Million)

5.4.10.  Spain

5.4.10.1.      Spain Market size and forecast, 2016-2026 (USD Million)

5.4.11.  Rest of Europe

5.4.11.1.      Rest of Europe Market size and forecast, 2016-2026 (USD Million)

5.5.        Asia Pacific

5.5.1.     Asia Pacific Inflammatory Bowel Disease Treatment Market size and forecast, 2016-2026

5.5.2.     Asia Pacific Inflammatory Bowel Disease Treatment Market, by Country, 2019 & 2026 (USD Million)

5.5.3.     Asia Pacific Inflammatory Bowel Disease Treatment Market, by Type, 2016-2026

5.5.3.1.         Asia Pacific Inflammatory Bowel Disease Treatment Market, by Type, 2016-2026 (USD Million)

5.5.4.     Asia Pacific Inflammatory Bowel Disease Treatment Market, by Route of Administration, 2016-2026

5.5.4.1.         Asia Pacific Inflammatory Bowel Disease Treatment Market, by Route of Administration, 2016-2026 (USD Million)

5.5.5.     Asia Pacific Inflammatory Bowel Disease Treatment Market, by Distribution Channel, 2016-2026

5.5.5.1.         Asia Pacific Inflammatory Bowel Disease Treatment Market, by Distribution Channel, 2016-2026 (USD Million)

5.5.6.     China

5.5.6.1.         China Market size and forecast, 2016-2026 (USD Million)

5.5.7.     Japan

5.5.7.1.         Japan Market size and forecast, 2016-2026 (USD Million)

5.5.8.     India

5.5.8.1.         India Market size and forecast, 2016-2026 (USD Million)

5.5.9.     South  Korea

5.5.9.1.         South  Korea Market size and forecast, 2016-2026 (USD Million)

5.5.10.  South-East Asia

5.5.10.1.      South-East Asia Market size and forecast, 2016-2026 (USD Million)

5.5.11.  Rest of Asia Pacific

5.5.11.1.      Rest of Asia Pacific Market size and forecast, 2016-2026 (USD Million)

5.6.        Latin America

5.6.1.     Latin America Inflammatory Bowel Disease Treatment Market size and forecast, 2016-2026

5.6.2.     Latin America Inflammatory Bowel Disease Treatment Market, by Country, 2019 & 2026 (USD Million)

5.6.3.     Latin America Inflammatory Bowel Disease Treatment Market, by Type, 2016-2026

5.6.3.1.         Latin America Inflammatory Bowel Disease Treatment Market, by Type, 2016-2026 (USD Million)

5.6.4.     Latin America Inflammatory Bowel Disease Treatment Market, by Route of Administration, 2016-2026

5.6.4.1.         Latin America Inflammatory Bowel Disease Treatment Market, by Route of Administration, 2016-2026 (USD Million)

5.6.5.     Latin America Inflammatory Bowel Disease Treatment Market, by Distribution Channel, 2016-2026

5.6.5.1.         Latin America Inflammatory Bowel Disease Treatment Market, by Distribution Channel, 2016-2026 (USD Million)

5.6.6.     Brazil

5.6.6.1.         Brazil Market size and forecast, 2016-2026 (USD Million)

5.6.7.     Mexico

5.6.7.1.         Mexico Market size and forecast, 2016-2026 (USD Million)

5.6.8.     Rest of Latin America

5.6.8.1.         Rest of Latin America Market size and forecast, 2016-2026 (USD Million)

5.7.        The Middle-East and Africa

5.7.1.     The Middle-East and Africa Inflammatory Bowel Disease Treatment Market size and forecast, 2016-2026

5.7.2.     The Middle-East and Africa Inflammatory Bowel Disease Treatment Market, by Country, 2019 & 2026 (USD Million)

5.7.3.     The Middle-East and Africa Inflammatory Bowel Disease Treatment Market, by Type, 2016-2026

5.7.3.1.         The Middle-East and Africa Inflammatory Bowel Disease Treatment Market, by Type, 2016-2026 (USD Million)

5.7.4.     The Middle-East and Africa Inflammatory Bowel Disease Treatment Market, by Route of Administration, 2016-2026

5.7.4.1.         The Middle-East and Africa Inflammatory Bowel Disease Treatment Market, by Route of Administration, 2016-2026 (USD Million)

5.7.5.     The Middle-East and Africa Inflammatory Bowel Disease Treatment Market, by Distribution Channel, 2016-2026

5.7.5.1.         The Middle-East and Africa Inflammatory Bowel Disease Treatment Market, by Distribution Channel, 2016-2026 (USD Million)

5.7.6.     GCC Countries

5.7.6.1.         GCC Countries Market size and forecast, 2016-2026 (USD Million)

5.7.7.     South Africa

5.7.7.1.         South Africa Market size and forecast, 2016-2026 (USD Million)

5.7.8.     Rest of Middle-East Africa

5.7.8.1.         Rest of Middle-East Africa Market size and forecast, 2016-2026 (USD Million)

CHAPTER 6.... Inflammatory Bowel Disease Treatment market – Competitive Landscape

6.1.        Competitor Market Share – Revenue

6.2.        Market Concentration Rate Analysis, Top 3 and Top 5 Players

6.3.        Strategic Development

6.3.1.     Acquisitions and Mergers

6.3.2.     New Products

6.3.3.     Research & Development Activities

CHAPTER 7.... Company Profiles

7.1.        Johnson & Johnson Services Inc.

7.1.1.     Company Overview

7.1.2.     Johnson & Johnson Services Inc. Revenue and Gross Margin

7.1.3.     Product portfolio

7.1.4.     Recent initiatives

7.2.        Pfizer Inc.

7.2.1.     Company Overview

7.2.2.     Pfizer Inc. Revenue and Gross Margin

7.2.3.     Product portfolio

7.2.4.     Recent initiatives

7.3.        Takeda Pharmaceutical Company Limited

7.3.1.     Company Overview

7.3.2.     Takeda Pharmaceutical Company Limited Revenue and Gross Margin

7.3.3.     Product portfolio

7.3.4.     Recent initiatives

7.4.        AbbVie Inc.

7.4.1.     Company Overview

7.4.2.     AbbVie Inc. Revenue and Gross Margin

7.4.3.     Product portfolio

7.4.4.     Recent initiatives

7.5.        Celltrion Healthcare Co., Ltd.

7.5.1.     Company Overview

7.5.2.     Celltrion Healthcare Co., Ltd. Revenue and Gross Margin

7.5.3.     Product portfolio

7.5.4.     Recent initiatives

7.6.        CELGENE CORPORATION

7.6.1.     Company Overview

7.6.2.     CELGENE CORPORATION Revenue and Gross Margin

7.6.3.     Product portfolio

7.6.4.     Recent initiatives

7.7.        COSMO PHARMACEUTICALS

7.7.1.     Company Overview

7.7.2.     COSMO PHARMACEUTICALS Revenue and Gross Margin

7.7.3.     Product portfolio

7.7.4.     Recent initiatives

7.8.        Innovate Biopharmaceuticals; UCB S.A.

7.8.1.     Company Overview

7.8.2.     Innovate Biopharmaceuticals; UCB S.A. Revenue and Gross Margin

7.8.3.     Product portfolio

7.8.4.     Recent initiatives

7.9.        Gilead Sciences.

7.9.1.     Company Overview

7.9.2.     Gilead Sciences. Revenue and Gross Margin

7.9.3.     Product portfolio

7.9.4.     Recent initiatives

CHAPTER 8.... Inflammatory Bowel Disease Treatment — Industry Analysis

8.1.        Inflammatory Bowel Disease Treatment Market – Key Trends

8.1.1.     Market Drivers

8.1.2.     Market Restraints

8.1.3.     Market Opportunities

8.2.        Value Chain Analysis

8.3.        Technology Roadmap and Timeline

8.4.        Inflammatory Bowel Disease Treatment Market – Attractiveness Analysis

8.4.1.     By Type

8.4.2.     By Route of Administration

8.4.3.     By Distribution Channel

8.4.4.     By Region

CHAPTER 9.... Marketing Strategy Analysis, Distributors

9.1.        Marketing Channel

9.2.        Direct Marketing

9.3.        Indirect Marketing

9.4.        Marketing Channel Development Trend

9.5.        Economic/Political Environmental Change

CHAPTER 10. Report Conclusion

CHAPTER 11. Research Approach & Methodology

11.1.      Report Description

11.2.      Research Scope

11.3.      Research Methodology

11.3.1.  Secondary Research

11.3.2.  Primary Research

11.3.3.  Models

11.3.3.1.      Company Share Analysis Model

11.3.3.2.      Revenue Based Modeling

11.3.3.3.              Research Limitations

List of Figures

FIG. 1    Global Inflammatory Bowel Disease Treatment Market, 2016-2026 (USD Million)
FIG. 2    Global Inflammatory Bowel Disease Treatment Market Share, by Type, 2019 & 2026 (USD Million)
FIG. 3    Global Crohn’s disease Inflammatory Bowel Disease Treatment Market, 2016-2026 (USD Million)
FIG. 4    Global Ulcerative colitis Inflammatory Bowel Disease Treatment Market, 2016-2026 (USD Million)
FIG. 5    Global Inflammatory Bowel Disease Treatment Market Share, by Route of Administration, 2019 & 2026 (USD Million)
FIG. 6    Global Injectables Inflammatory Bowel Disease Treatment Market, 2016-2026 (USD Million)
FIG. 7    Global Oral Inflammatory Bowel Disease Treatment Market, 2016-2026 (USD Million)
FIG. 8    Global Inflammatory Bowel Disease Treatment Market Share, by Distribution Channel, 2019 & 2026 (USD Million)
FIG. 9    Global Hospital Pharmacy Inflammatory Bowel Disease Treatment Market, 2016-2026 (USD Million)
FIG. 10    Global Retail Pharmacy Inflammatory Bowel Disease Treatment Market, 2016-2026 (USD Million)
FIG. 11    Global Other Pharmacy Inflammatory Bowel Disease Treatment Market, 2016-2026 (USD Million)
FIG. 12    Global Inflammatory Bowel Disease Treatment Market Share, by Region, 2019 & 2026
FIG. 13    North America Inflammatory Bowel Disease Treatment Market, 2016-2026
FIG. 14    U.S. Inflammatory Bowel Disease Treatment Market, 2016-2026
FIG. 15    Canada Inflammatory Bowel Disease Treatment Market, 2016-2026
FIG. 16    Europe Inflammatory Bowel Disease Treatment Market, 2016-2026
FIG. 17    Germany Inflammatory Bowel Disease Treatment Market, 2016-2026
FIG. 18    France Inflammatory Bowel Disease Treatment Market, 2016-2026
FIG. 19    U.K. Inflammatory Bowel Disease Treatment Market, 2016-2026
FIG. 20    Italy Inflammatory Bowel Disease Treatment Market, 2016-2026
FIG. 21    Spain Inflammatory Bowel Disease Treatment Market, 2016-2026
FIG. 22    Rest of Europe Inflammatory Bowel Disease Treatment Market, 2016-2026
FIG. 23    Asia Pacific Inflammatory Bowel Disease Treatment Market, 2016-2026
FIG. 24    China Inflammatory Bowel Disease Treatment Market, 2016-2026
FIG. 25    Japan Inflammatory Bowel Disease Treatment Market, 2016-2026
FIG. 26    India Inflammatory Bowel Disease Treatment Market, 2016-2026
FIG. 27    South  Korea Inflammatory Bowel Disease Treatment Market, 2016-2026
FIG. 28    South-East Asia Inflammatory Bowel Disease Treatment Market, 2016-2026
FIG. 29    Rest of Asia Pacific Inflammatory Bowel Disease Treatment Market, 2016-2026
FIG. 30    Latin America Inflammatory Bowel Disease Treatment Market, 2016-2026
FIG. 31    Brazil Inflammatory Bowel Disease Treatment Market, 2016-2026
FIG. 32    Mexico Inflammatory Bowel Disease Treatment Market, 2016-2026
FIG. 33    Rest of Latin America Inflammatory Bowel Disease Treatment Market, 2016-2026
FIG. 34    The Middle-East and Africa Inflammatory Bowel Disease Treatment Market, 2016-2026
FIG. 35    GCC Countries Inflammatory Bowel Disease Treatment Market, 2016-2026
FIG. 36    South Africa Inflammatory Bowel Disease Treatment Market, 2016-2026
FIG. 37    Rest of Middle-East Africa Inflammatory Bowel Disease Treatment Market, 2016-2026
FIG. 38    Competitor Market Share – Revenue
FIG. 39    Johnson & Johnson Services Inc. Revenue and Growth Rate
FIG. 40    Johnson & Johnson Services Inc. Market Share
FIG. 41    Pfizer Inc. Revenue and Growth Rate
FIG. 42    Pfizer Inc. Market Share
FIG. 43    Takeda Pharmaceutical Company Limited Revenue and Growth Rate
FIG. 44    Takeda Pharmaceutical Company Limited Market Share
FIG. 45    AbbVie Inc. Revenue and Growth Rate
FIG. 46    AbbVie Inc. Market Share
FIG. 47    Celltrion Healthcare Co., Ltd. Revenue and Growth Rate
FIG. 48    Celltrion Healthcare Co., Ltd. Market Share
FIG. 49    CELGENE CORPORATION Revenue and Growth Rate
FIG. 50    CELGENE CORPORATION Market Share
FIG. 51    COSMO PHARMACEUTICALS Revenue and Growth Rate
FIG. 52    COSMO PHARMACEUTICALS Market Share
FIG. 53    Innovate Biopharmaceuticals; UCB S.A. Revenue and Growth Rate
FIG. 54    Innovate Biopharmaceuticals; UCB S.A. Market Share
FIG. 55    Gilead Sciences. Revenue and Growth Rate
FIG. 56    Gilead Sciences. Market Share
FIG. 57    Market Dynamics
FIG. 58    Global Inflammatory Bowel Disease Treatment – Value Chain Analysis
FIG. 59    Technology Roadmap and Timeline
FIG. 60    Market Attractiveness Analysis – By Type
FIG. 61    Market Attractiveness Analysis – By Route of Administration
FIG. 62    Market Attractiveness Analysis – By Distribution Channel
FIG. 63    Market Attractiveness Analysis – By Region
FIG. 64    Market Channel
FIG. 65    Marketing Channel Development Trend
FIG. 66    Growth in World Gross Product, 2008-2018
 

List of Tables

TABLE 1    Global Inflammatory Bowel Disease Treatment Market, 2019 & 2026 (USD Million)
TABLE 2    Global Inflammatory Bowel Disease Treatment market, by Type, 2016-2026 (USD Million)
TABLE 3    Global Inflammatory Bowel Disease Treatment market, by Route of Administration, 2016-2026 (USD Million)
TABLE 4    Global Inflammatory Bowel Disease Treatment market, by Distribution Channel, 2016-2026 (USD Million)
TABLE 5    Global Inflammatory Bowel Disease Treatment market, by Region, 2016-2026 (USD Million)
TABLE 6    North America Inflammatory Bowel Disease Treatment Market, by Type, 2016-2026 (USD Million)
TABLE 7    North America Inflammatory Bowel Disease Treatment Market, by Route of Administration, 2016-2026 (USD Million)
TABLE 8    North America Inflammatory Bowel Disease Treatment Market, by Distribution Channel, 2016-2026 (USD Million)
TABLE 9    Europe Inflammatory Bowel Disease Treatment Market, by Type, 2016-2026 (USD Million)
TABLE 10    Europe Inflammatory Bowel Disease Treatment Market, by Route of Administration, 2016-2026 (USD Million)
TABLE 11    Europe Inflammatory Bowel Disease Treatment Market, by Distribution Channel, 2016-2026 (USD Million)
TABLE 12    Asia Pacific Inflammatory Bowel Disease Treatment Market, by Type, 2016-2026 (USD Million)
TABLE 13    Asia Pacific Inflammatory Bowel Disease Treatment Market, by Route of Administration, 2016-2026 (USD Million)
TABLE 14    Asia Pacific Inflammatory Bowel Disease Treatment Market, by Distribution Channel, 2016-2026 (USD Million)
TABLE 15    Latin America Inflammatory Bowel Disease Treatment Market, by Type, 2016-2026 (USD Million)
TABLE 16    Latin America Inflammatory Bowel Disease Treatment Market, by Route of Administration, 2016-2026 (USD Million)
TABLE 17    Latin America Inflammatory Bowel Disease Treatment Market, by Distribution Channel, 2016-2026 (USD Million)
TABLE 18    The Middle-East and Africa Inflammatory Bowel Disease Treatment Market, by Type, 2016-2026 (USD Million)
TABLE 19    The Middle-East and Africa Inflammatory Bowel Disease Treatment Market, by Route of Administration, 2016-2026 (USD Million)
TABLE 20    The Middle-East and Africa Inflammatory Bowel Disease Treatment Market, by Distribution Channel, 2016-2026 (USD Million)
TABLE 21    Global Inflammatory Bowel Disease Treatment Market - Company Revenue Analysis 2015-2018 (USD Million)
TABLE 22    Global Inflammatory Bowel Disease Treatment Market - Company Revenue Share Analysis 2015-2018(%)
TABLE 23    Acquisitions and Mergers
TABLE 24    New Product/Service Launch
TABLE 25    Research & Development Activities
TABLE 26    Market Drivers
TABLE 27    Market Restraints
TABLE 28    Market Opportunities
 

Industry Major Market Players

  • Johnson & Johnson Services Inc.
  •  Pfizer Inc.
  •  Takeda Pharmaceutical Company Limited
  •  AbbVie Inc.
  •  Celltrion Healthcare Co.  Ltd.
  •  CELGENE CORPORATION
  •  COSMO PHARMACEUTICALS
  •  Innovate Biopharmaceuticals
  •  UCB S.A.
  • Gilead Sciences

paypal
Copyright © 2023 - 2024, All Rights Reserved, Facts and Factors